"In unserem Centrum für Angiologie und Kardiologie Frankfurt stehen die Erkennung und Behandlung von Erkrankungen des Herzens, des Herz-Kreislauf-Systems und der Gefäße im Vordergrund. Wir führen Ultraschalluntersuchungen, EKG-Untersuchungen sowie Herzkatheteruntersuchungen durch und nehmen minimal-invasive Eingriffe im Herzkatheterlabor vor. Im Rahmen der Angiologie behandeln wir Krankheiten der Arterien und Venen."

During the past decade, CardioVasculäres Centrum Frankfurt conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CardioVasculäres Centrum Frankfurt" #1 sponsor was "Contego Medical, Inc." with 2 trials, followed by "Johann Wolfgang Goethe University Hospital" with 2 trials sponsored, "Occlutech International AB" with 2 trials sponsored, "ResMed" with 2 trials sponsored and "Atrium Medical Corporation" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CardioVasculäres Centrum Frankfurt" #1 collaborator was "CERES GmbH" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "Food and Drug Administration (FDA)" with 1 trials as a collaborator, "Horizon 2020 - European Commission" with 1 trials as a collaborator and "RenalGuard Solutions, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CardioVasculäres Centrum Frankfurt" are "Heart Failure" (3 trials), "Abdominal Aortic Aneurysm" (1 trials), "Acute Kidney Injury" (1 trials), "Aortic Valve Disorder" (1 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "CardioVasculäres Centrum Frankfurt" in a lesser frequency.

Most popular intervention types in "CardioVasculäres Centrum Frankfurt" are "Device" (16 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "BAROSTIM NEO™ System" (1 trials), "Control" (1 trials), "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials), "Intraarterial bone marrow progenitor cell transplantation" (1 trials) and "LAmbre occluder" (1 trials). Other intervention names were less common.

The vast majority of trials in "CardioVasculäres Centrum Frankfurt" are 20 trials for "All" genders.

Currently, there are NaN active trials in "CardioVasculäres Centrum Frankfurt". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in CardioVasculäres Centrum Frankfurt, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CardioVasculäres Centrum Frankfurt, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".